Stop Deadly Denials Act of 2026
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Stop Deadly Denials Act of 2026, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Transportation, Technology.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H50CD3D997F794E45B123F6F61921F8E1: 1. Short title This Act may be cited as the Stop Deadly Denials Act of 2026.
- Section HFEFBE74DA5714331935E7AF7767CE07A: 2. Prohibiting prior authorization requirements in Medicare Advantage Section 1852 of the Social Security Act (42 U.S.C. 1395w–22) is amended by adding at the...
- Section H031B7F06B3574EF184E1CC85C369A258: 3. Limiting implementation of Center for Medicare and Medicaid Innovation models testing prior authorization under traditional Medicare The Secretary of Health...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Stop Deadly Denials Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Transportation, Technology
Primary Purpose
This bill, Stop Deadly Denials Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeReferred to the Committee on Ways and Means, and in …
Introduced in House
Mr. Khanna (for himself, Ms. Jayapal, Mr. Cohen, Mrs. Dingell, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology